Activation of the MAPK and phosphatidylinositol 3 kinase/Akt/mTOR pathways plays a crucial role in the control of cell growth and survival in ovarian cancer, and inhibition of these pathways leads to the inhibition of ovarian cancer growth. The gene discussed is MTOR; the disease is ovarian cancer.